Indonesia becomes Asian hotspot after new case sudden surge this week

0
940
The Health Ministry of Indonesia reported 54,517 new cases and 991 deaths on Wednesday, bringing the number of confirmed cases since the pandemic began above 2.6 million and the number of confirmed fatalities to more than 69,000.

Indonesia reported more than 54,000 new coronavirus cases for the first time Wednesday, surpassing recent daily infections in India, whose disastrous outbreak is declining, and becoming Asia’s new virus hotspot.

Officials fear that the more highly transmissible delta variant is now spreading from the islands of Java and Bali, where outbreaks prompted a partial lockdown that closed places of worship, malls, parks and restaurants.



The Health Ministry reported 54,517 new cases and 991 deaths on Wednesday, bringing the number of confirmed cases since the pandemic began above 2.6 million and the number of confirmed fatalities to more than 69,000.

A month ago, daily cases were running at about 8,000.

Reported daily cases in Indonesia are now higher than in India, despite Indonesia having far less testing by population.

India reported fewer than 39,000 cases on Wednesday, far below its peak of more than 400,000 daily cases in May, following lockdowns in its worst-hit areas and a stepped-up vaccination drive.

Indonesian Health Minister Budi Gunadi Sadikin said the government has identified the spread of the delta variant in some regions outside Java and Bali.


He told lawmakers on Tuesday that across the country, more than 90,000 of the 120,000 hospital beds for COVID-19 patients are occupied.

With the increase in deaths over the past month, some residents near Jakarta have begun helping overburdened gravediggers.



The government is struggling to acquire enough vaccines to reach its target of inoculating more than 181 million of its 270 million people by March 2022. So far, only 15.6 million people have been fully vaccinated.

So far, the world’s fourth-most populous country has secured 137.6 million doses of Sinovac, AstraZeneca and Moderna vaccines, enough for about 69 million people. (NNT)